<DOC>
	<DOCNO>NCT02162420</DOCNO>
	<brief_summary>Fludarabine-based preparative regimen follow allogeneic hematopoietic stem cell transplant use relate unrelated donor person 0-70 year age diagnose dyskeratosis congenita severe aplastic anemia bone marrow failure characterize requirement red blood cell platelet transfusion . Three different preparative regimen include base disease donor type .</brief_summary>
	<brief_title>Hematopoietic Stem Cell Transplant Dyskeratosis Congenita Severe Aplastic Anemia</brief_title>
	<detailed_description />
	<mesh_term>Anemia</mesh_term>
	<mesh_term>Anemia , Aplastic</mesh_term>
	<mesh_term>Dyskeratosis Congenita</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Fludarabine phosphate</mesh_term>
	<mesh_term>Antilymphocyte Serum</mesh_term>
	<mesh_term>Fludarabine</mesh_term>
	<mesh_term>Alemtuzumab</mesh_term>
	<mesh_term>Vidarabine</mesh_term>
	<criteria>Aged 0 70 year Acceptable hematopoeitic stem cell donor Dyskeratosis Congenita ( DC ) evidence BM failure define : requirement red blood cell and/or platelet transfusion requirement GCSF GMCSF erythropoietin refractory cytopenias one follow three platelet &lt; 50,000/uL transfusion dependent absolute neutrophil count &lt; 500/uL without hematopoietic growth factor support hemoglobin &lt; 9g/uL transfusion dependent Diagnosis DC triad mucocutaneous feature : oral leukoplakia nail dystrophy abnormal reticular skin hyperpigmentation Diagnosis DC one following : short telomere ( research study ) mutation telomerase holoenzyme ( DKC1 , TERT , TERC , NOP10 , NHP2 , TCAB1 ) mutation shelterin complex ( TINF2 ) mutation telomerecapping complex ( CTC1 ) Severe Aplastic Anemia ( SAA ) evidence BM failure Severe Aplastic Anemia ( SAA ) refractory cytopenias one follow three : platelet &lt; 20,000/uL transfusion dependent absolute neutrophil count &lt; 500/uL without hematopoietic growth factor support absolute reticulocyte count &lt; 20,000/uL Early myelodysplastic feature With without clonal cytogenetic abnormality Adequate organ function define : cardiac : leave ventricular ejection fraction ≥ 35 % evidence decompensated heart failure pulmonary : DLCO ≥30 % predict , supplemental oxygen requirement renal : Glomerular filtration rate ( GFR ) ≥30 % predict Voluntary write consent Acute hepatitis evidence moderate severe portal fibrosis cirrhosis biopsy Pregnant lactating Uncontrolled infection Prior radiation therapy Diagnosis Fanconi anemia base DEB Diagnosis dyskeratosis congenita advance MDS acute myeloid leukemia &gt; 30 % blast</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>severe aplastic anemia</keyword>
	<keyword>Hematopoietic Stem Cell Transplant</keyword>
</DOC>